KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal Health Services (UHS) Other financing activities (2016 - 2025)

Universal Health Services (UHS) has disclosed Other financing activities for 15 consecutive years, with -$11.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other financing activities fell 378.44% year-over-year to -$11.0 million, compared with a TTM value of $382000.0 through Dec 2025, down 97.06%, and an annual FY2025 reading of $382000.0, down 97.06% over the prior year.
  • Other financing activities was -$11.0 million for Q3 2025 at Universal Health Services, down from $6.9 million in the prior quarter.
  • Across five years, Other financing activities topped out at $7.6 million in Q1 2021 and bottomed at -$11.0 million in Q3 2025.
  • Average Other financing activities over 5 years is $2.0 million, with a median of $2.4 million recorded in 2023.
  • The sharpest move saw Other financing activities skyrocketed 518000.0% in 2024, then crashed 378.44% in 2025.
  • Year by year, Other financing activities stood at $5.7 million in 2021, then tumbled by 89.12% to $623000.0 in 2022, then soared by 277.85% to $2.4 million in 2023, then soared by 70.82% to $4.0 million in 2024, then crashed by 372.42% to -$11.0 million in 2025.
  • Business Quant data shows Other financing activities for UHS at -$11.0 million in Q3 2025, $6.9 million in Q2 2025, and $4.4 million in Q1 2025.